CERO THERAPEUTICS HOLDINGS, INC. - 10-Q Filing
Cero Therapeutics Holdings, Inc. reports Q3 financial results and discloses significant subsequent events including a legal settlement and Series E preferred stock agreements.
Tickers: $PBAXU
Cero Therapeutics Holdings, Inc. reports Q3 financial results and discloses significant subsequent events including a legal settlement and Series E preferred stock agreements.
Tickers: $PBAXU